Abstract:As an abrupt epidemic occurs, healthcare systems are shocked by the surge in the number of susceptible patients' demands, and decision-makers mostly rely on their frame of reference for urgent decision-making. Many reports have declared the COVID-19 impediments to trading and global economic growth. This study aims to provide a mathematical model to support pharmaceutical supply chain planning during the COVID-19 epidemic. Additionally, it aims to offer new insights into hospital supply chain problems by unifying cold and non-cold chains and considering a wide range of pharmaceuticals and vaccines. This approach is unprecedented and includes an analysis of various pharmaceutical features such as temperature, shelf life, priority, and clustering. To propose a model for planning the pharmaceutical supply chains, a mixed-integer linear programming (MILP) model is used for a four-echelon supply chain design. This model aims to minimize the costs involved in the pharmaceutical supply chain by maintaining an acceptable service level. Also, this paper considers uncertainty as an intrinsic part of the problem and addresses it through the wait-and-see method. Furthermore, an unexplored unsupervised learning method in the realm of supply chain planning has been used to cluster the pharmaceuticals and the vaccines and its merits and drawbacks are proposed. A case of Tehran hospitals with real data has been used to show the model's capabilities, as well. Based on the obtained results, the proposed approach is able to reach the optimum service level in the COVID conditions while maintaining a reduced cost. The experiment illustrates that the hospitals' adjacency and emergency orders alleviated the service level significantly. The proposed MILP model has proven to be efficient in providing a practical intuition for decision-makers. The clustering technique reduced the size of the problem and the time required to solve the model considerably.

The Distribution of Vaccine among Countries in the Case of a Pandemic

Vaccination Schedule under Conditions of Limited Vaccine Production Rate

Strategic spatiotemporal vaccine distribution increases the survival rate in an infectious disease like Covid-19

Inventory policy for the vaccine of a new pandemic

International Vaccine Allocation: An Optimization Framework

An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty

Pursuing equitable access to vaccines for the next epidemic

Designing a sustainable vaccine supply chain by considering demand substitution and value-added function during a pandemic outbreak

Equitable vaccine distribution promotes socioeconomic benefits globally

Optimal COVID-19 Vaccine Sharing Between Two Nations That Also Have Extensive Travel Exchanges

Supply Chains Create Global Benefits from Improved Vaccine Accessibility

Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic

Waiting for the Perfect Vaccine

Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.

Optimizing COVID-19 vaccine distribution adding spatio-temporal criteria

Where to locate COVID-19 mass vaccination facilities?

A humanitarian cold supply chain distribution model with equity consideration: The case of COVID-19 vaccine distribution in the European Union

Supply chain planning of vaccine and pharmaceutical clusters under uncertainty: The case of COVID-19

An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic

Optimization modeling for pandemic vaccine supply chain management: A review and future research opportunities

On Efficient Vaccine Distribution Strategy to Suppress Pandemic Using Social Relation.